EXACT sciences corp. –

Maynard, Mass.

Went public 01/31/01

Filing Range:4.0 million shares @ $14 to $16

Shares Outstanding: 18.6 million shares

Underwriters: Merrill Lynch & Co. Inc./CIBC World Markets/ Thomas Weisel Partners LLC

Company Counsel: Testa Hurwitz & Thibeault

Manager Counsel: Shearman & Sterling

Auditor: Arthur Andersen LLP

The Company:

Develops stool-based early detection test for colorectal cancer. The company has developed proprietary technologies in applied genomics that aids in the early detection of colorectal cancer and several other types of common cancers.

Venture Backers:

Highland Capital Partners

OneLiberty Ventures

Greylock Management Corp.

Boston University Community Technology Fund

CB Health Ventures LLC

Robertson Stephens Inc.

HLM Management Co.

PaineWebber Group Inc./McKinley Allsop

Vulcan Ventures Inc.

Galleon Management Inc.

Mayo Medical Ventures

BancBoston

Gilde Venture Fund

Financing Rounds:

Number ofRound Amt.

Round # Round Date Stage Investors ($ thousands)

1 02/01/1995 3 Early Stage 200.0

2 02/01/1996 1 Early Stage 99.0

3 04/01/1996 3 Early Stage 800.1

4 02/01/1997 5 Early Stage 3935.0

5 03/17/1998 10 Expansion 10575.2

6 04/03/2000 19 Later Stage 31895.0

Financials:

(Data in $ millions)

Y/E

12/31/00

Total Revenues: $0.0

Net Income (5.0)